arrow
N

Nicole L. Messina

Murdoch Children's Research Institute
H指数:23
被引数:2,904

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial

利用血清学和PCR/快速抗原检测优化COVID-19发病期识别:BRACE试验的启示

2026-04-070
OAAI
Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR Trial

1至5岁特应性致敏的变化:MIS BAIR试验的纵向数据

2025-09-220
OAAI
Neonatal BCG Vaccination Decreases Eczema Incidence at 5 years: The MIS BAIR Randomised Controlled Trial

新生儿卡介苗接种降低5年湿疹发生率:MIS BAIR随机对照试验

2025-07-310
OAAI
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination

卡介苗接种对SARS-CoV-2及COVID-19疫苗接种的免疫反应的影响

2025-01-250
OAAI
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: Insights from prospectively collected data in the BRACE trial

新型冠状病毒肺炎和其他呼吸系统疾病的前期和持续性症状: 来自BRACE试验中前瞻性收集数据的见解

2024-11-011
OAAI
BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial

医护人员接种卡介苗预防新型冠状病毒肺炎: 一项国际随机对照试验的12个月结果

2024-10-011
OAAI
Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled Trial
2024-07-141
OAAI
Accelerated Bacille Calmette-Guerin reactions: More than meets the eye
HELIYON
IF3.6
2024-07-010
OAAI
Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial
2024-06-018
OAAI
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

卡介苗疫苗预防成人发热和呼吸系统疾病 (BRACE): 一项随机对照3期试验的次要结果

2024-06-011
OAAI
Speci fi c and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines - an exploratory sub-study of the BRACE trial

新型冠状病毒肺炎接种ChAdOx1-S和BNT162b2疫苗后的特异性和脱靶免疫反应-BRACE试验的探索性子研究

2024-05-011
OAAI
Bacillus Calmette-Guerin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
2023-10-012
OAAI